Lake Street lowered the firm's price target on Alkami to $27 from $34 and keeps a Buy rating on the shares. While 2026 revenue guidance was short of consensus, the firm views the shortfall as "a function of positive underlying factors rather than a deterioration in the end market," the analyst tells investors. The firm is lowering its price target as a result of SaaS multiple compression, the analyst noted.
